What are the advertising rules for speech pathologists in Australia?
CompliGUARD reviews this compliance area against TGA · AHPRA · FSANZ · ACCC frameworks for Australian health brands — here's what the regulations say.
CompliGUARD reviews speech pathologist advertising for compliance risk before publication. Speech pathologists are registered with AHPRA under the Speech Pathology Board of Australia and must comply with all advertising prohibitions under s.133 of the Health Practitioner Regulation National Law — including the ban on patient testimonials, unrealistic outcome claims, unsubstantiated superiority claims, and inducements.
The rule: Health Practitioner Regulation National Law, s.133; AHPRA Guidelines for Advertising a Regulated Health Service, December 2020; Speech Pathology Board Advertising Guidance
Speech pathology is one of 15 professions regulated by AHPRA under the Health Practitioner Regulation National Law. All speech pathologist advertising — including websites, social media, directories, clinic signage, and any other promotional channel — is subject to s.133 and the AHPRA Guidelines for Advertising a Regulated Health Service. The Speech Pathology Board of Australia has endorsed the AHPRA advertising guidelines and expects practitioners to apply them across all advertising. Speech pathologists working in paediatric communication, swallowing disorders, stuttering, and acquired neurological communication disorders face specific risks from outcome-based advertising claims given the complexity and variability of treatment outcomes in these areas.
What this means in practice
- Do not publish patient or client testimonials in any form — including written accounts, video content, parent testimonials for paediatric clients, or reposted online reviews.
- Do not make claims that speech pathology will achieve a specific communication outcome — 'your child will speak clearly', 'stutter resolved in 12 sessions', 'fluency guaranteed' — these are unrealistic outcome claims under s.133(1)(c).
- Exercise particular caution with paediatric communication claims — implied outcome promises for children with autism, developmental delays, or language disorders are high-risk under s.133(1)(c).
- Do not claim superiority over other speech pathology approaches or practitioners without substantiated evidence — 'our method is more effective' requires peer-reviewed support.
- Retain pre-publication compliance records for all advertising content — AHPRA's automated monitoring tools scan speech pathologist websites and social media.
Common mistakes
Publishing parent testimonials for paediatric clients
Parent testimonials about their child's speech pathology outcomes are testimonials under s.133(1)(c) — the prohibition applies to testimonials from any person about the service, not only the patient directly. A parent's account of their child's progress in advertising is a prohibited testimonial.
Replace parent outcome stories with educational content about paediatric communication development, what to expect from an assessment, and the evidence base for speech pathology intervention.
Making milestone-based outcome claims for paediatric communication
Claims that a child will achieve specific communication milestones following speech pathology — 'talking in sentences by six months', 'school-ready speech by prep' — create unrealistic expectations under s.133(1)(c). Communication development is highly individual and outcome timelines cannot be guaranteed.
Describe the speech pathology process — assessment, evidence-based intervention, family involvement — without implying specific outcome timelines or milestones.
Promoting proprietary speech therapy programmes with superiority claims
Claims that a proprietary programme or method is definitively superior to established evidence-based approaches require peer-reviewed evidence to substantiate. Where that evidence does not exist or is limited, the claim is an unsubstantiated superiority claim under s.133(1)(d).
Describe your therapeutic approach and its evidence base accurately. Where a programme has been evaluated, cite the evidence. Do not claim superiority over other approaches without that evidence.
Compliant vs non-compliant example
❌ NON-COMPLIANT
Publishing parent testimonials for paediatric clients
✅ COMPLIANT
Replace parent outcome stories with educational content about paediatric communication development, what to expect from an assessment, and the evidence base for speech pathology intervention.
The enforcement context
AHPRA's advertising complaint process covers speech pathology, and the Speech Pathology Board actively monitors advertising compliance. AHPRA's automated monitoring tools scan practitioner websites and social media. Penalties for s.133 breaches reach $60,000 per offence for individuals. Speech pathologists advertising paediatric services face particular scrutiny given the vulnerability of the patient population.
Before you publish, check it.
CompliGUARD reviews speech pathologist advertising against AHPRA Guidelines s.133 — including outcome claim analysis, testimonial detection, and paediatric advertising risk flagging.
Start free reviewRelated questions
Regulatory references
- Health Practitioner Regulation National Law, s.133
- AHPRA Guidelines for Advertising a Regulated Health Service, December 2020
- Speech Pathology Board of Australia — Advertising Standards